Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Low-volume polyethylene glycol (PEG) plus ascorbic acid is an osmotic laxative bowel preparation solution used for colon cleansing prior to colonoscopy. It combines PEG-3350 with electrolytes (sodium sulfate, sodium chloride, potassium chloride) and ascorbic acid/sodium ascorbate, allowing effective bowel cleansing at a reduced volume of 2L compared to the standard 4L PEG solution. The ascorbic acid component acts as an additional osmotic laxative, enabling the volume reduction while maintaining efficacy and improving patient tolerability. It works by drawing water into the colon, increasing stool volume and stimulating bowel movements to clear the gastrointestinal tract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polyethylene glycol 3350 + electrolytes + ascorbic acid.